Processa pharmaceuticals doses first patient in amended phase 1b protocol for pcs6422 combined with capecitabine (next generation capecitabine)

Processa f ocuse s on i dentify ing the pcs6422 regimens to i ncrease c apecitabine potency while identifying the mtd of next generation capecitabine

PCSA Ratings Summary

PCSA Quant Ranking